Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details Narrative)

v3.22.4
Summary of Significant Accounting Policies (Details Narrative)
 12 Months Ended
Dec. 12, 2019
USD ($)
Jun. 19, 2018
Dec. 31, 2022
USD ($)
Segment
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Property, Plant and Equipment [Line Items]          
Number of operating segment | Segment     1    
Cash FDIC insured amount     $ 250    
Impairment loss     0 $ 0  
Accrual for interest or penalties     0    
Revenue     3,188,000 33,000  
Research and development, costs incurred     $ 811,000 2,179,000  
Per Molecules [Member] | Genentech [Member]          
Property, Plant and Equipment [Line Items]          
Revenue       $ 33,000 $ 33,000
Feasibility Study Agreement [Member] | Three Molecules [Member] | Genentech [Member]          
Property, Plant and Equipment [Line Items]          
Proceeds from sale of productive assets $ 100,000        
Feasibility Study Agreement [Member] | Per Molecules [Member] | Genentech [Member]          
Property, Plant and Equipment [Line Items]          
Proceeds from sale of productive assets $ 33,000        
Series B Preferred Stock [Member] | First Anniversary [Member]          
Property, Plant and Equipment [Line Items]          
Preferred stock dividend percent   10.00%      
Series B Preferred Stock [Member] | Second Anniversary [Member]          
Property, Plant and Equipment [Line Items]          
Preferred stock dividend percent   15.00%      
Series B Preferred Stock [Member] | Third Anniversary [Member]          
Property, Plant and Equipment [Line Items]          
Preferred stock dividend percent   20.00%      
Minimum [Member]          
Property, Plant and Equipment [Line Items]          
Leasehold improvements and equipment, useful life     3 years    
Maximum [Member]          
Property, Plant and Equipment [Line Items]          
Leasehold improvements and equipment, useful life     10 years